ReviewJournal of oral and maxillofacial pathology : JOMFP
Role of Forkhead box protein 3 in the pathogenesis of oral lichen planus: A systematic review.
Review in Journal of oral and maxillofacial pathology : JOMFP. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
0 citing papers in PubMed.
No citing paper in PubMed yet.
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
2 authors.
Funding
No grant is acknowledged in the PubMed record.
Abstract
Oral lichen planus (OLP) is a non-neoplastic immune-mediated chronic disease of the oral mucosa with malignant transformation potential into oral cancer. Immune-regulatory T cells and the transcription factor forkhead box protein 3 (FOXP3) are important in the control of immune function, but their definitive role in the disease process is not known. To assess the contribution of FOXP3-positive cells and associated immune mechanisms to the development and maintenance of OLP and to investigate their correlation with clinical disease activity. Published clinical, molecular, and immunohistochemical papers were analysed for patterns of expression and function of FOXP3-positive cells, inflammatory cytokines, and immune pathways in OLP. Data from descriptive and analytical studies were combined to gain insights into the pathogenesis. Higher numbers of FOXP3-positive cells are found regularly in OLP. The majority of these cells do not possess suppressive activity, which results in chronic inflammation. Dysregulation of immune-modulatory pathways, including the FOXP3-microRNA-nuclear factor kappa B axis, in association with heightened pro-inflammatory cytokines, correlates directly with disease activity. Variations in expression patterns also correlate with erosive and non-erosive clinical subtypes. FOXP3-positive cells play a pivotal role in the immune imbalance of OLP. Their existence indicates an attempt to regulate immune reactions, but functional impairment leads to persistent inflammation. Knowledge of these processes can assist in formulating targeted therapy and prognostication of disease progression.
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.